Showing posts with label CRO Industry. Show all posts
Showing posts with label CRO Industry. Show all posts

Tuesday, January 27, 2009

Free Webinar: The Benefits of Establishing a Governance Committee

February 26, 2:00pm-3:00pm EST

Space is limited.

Reserve your Webinar seat now

https://www1.gotomeeting.com/register/221347807

How does a Sponsor and a Service Provider work together collaboratively as a Partnership? One of the ways is to establish a Governance Committee. The Governance Committee will cultivate a better relationship between the CRO and Sponsor.

When should a governance committee be established?
How do you determine the membership of the Governance Committee?
What should be in the Charter?
What should the frequency be?
What is the value of the Governance Committee and how will this be measured?

Register Today!

Use code: G1P1400W1BLOG

Wednesday, October 29, 2008

CRO Stock Prices Going Down

This recent report, states that even though Contract Research Organizations have been reporting that their quarterly goals have been meet or exceeded, with the current market meltdown, this information is apparently not seen as relevant to investors. One reason cited for the stock prices of these corporations going down, despite company affirmations that they are fine, is the weakening dollar. Either way, it seems that short term investments are out of the questions.

Tuesday, September 16, 2008

Role of LIMS

This article from Bio-IT World reminds that it is important for CRO’s to use high-performance laboratory information management systems (LIMS). Sponsor companies and CRO’s who use LIMS, will see a lower “barrier entry” when dealing with regulatory agencies in respective countries. LIMS are helpful in gathering, analyzing and storing data for the CRO’s sponsors. It is especially important to be aware of regulations since on average bringing a new drug to market takes 15 years, and costs $2 billion.

Tuesday, August 19, 2008

ACRO Accepts New Members

As reported in market watch, the Association of Clinical Research Organizations (ACRO), has accepted two more members, Clinilabs, and RPS. Clinilabs specializes in dealing with the central nervous system and cardiovascular therapeutics. RPS, provides global Phase I-IV clinical development solutions.

David Spaight, ACRO Chair and President, released this statement:

"I am extremely pleased to welcome Clinilabs and RPS as new members of ACRO. Their involvement will enhance the association's ability to represent the CRO industry broadly to government officials, research sponsors, patient groups, and others international stakeholders. We invite all CROs to consider membership in our industry's trade association."